Table 3

Results of the HZ Questionnaire

Onset after SLE diagnosisFrequency (%)
1–5 years post-SLE diagnosis29 (35.4)
6–10 years post-SLE diagnosis12 (14.6%)
>10 years post-SLE diagnosis41 (50.0%)
HZ symptoms: occurrence of pain, itching, tingling with rash
 No4 (4.9%)
 Yes78 (95.1%)
Confirmed of HZ diagnosis by physician
 No1 (1.2%)
 Yes81 (98.8%)
Vaccination history: ever received varicella zoster vaccine
 No69 (84.2%)
 Yes13 (15.9%)
Hospitalisations: ever hospitalised for severe HZ?
 No69 (84.2%)
 Yes13 (15.9%)
Treatment for HZ : ever received treatments (eg, antivirals) for HZ?
 No16 (20%)
 Yes64 (80%)
 Missing2
Postherpetic neuralgia: history of severe pain after HZ infection?
 No35 (44.3%)
 Yes44 (55.7%)
Missing3
Duration of postherpetic neuralgia, if present
 3 months20 (48.8%)
 3–6 months7 (17.1%)
 >6 months14 (34.2%)
 Missing3
SLE treatments at time of HZ infection?
 Prednisone59 (71.9%)
 Hydroxychloroquine50 (61%)
 Azathioprine29 (35%)
 Mycophenolate mofetil or mycophenolic acid14 (17.1%)
 Cyclophosphamide2 (2.4%)
 Belimumab0 (0%)
 Rituximab2 (2.4%)
 Methotrexate4 (4.9%)
 Other treatment15 (18.3%)
Prednisone dose in mg/day, if taken
 FrequencyMissingMinimum doseMean doseSDMedian doseLower quartileUpper quartileMaximum dose
 2336122.319.51553060

  • HZ, herpes zoster.